<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nutritional issues in adult patients with cirrhosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nutritional issues in adult patients with cirrhosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nutritional issues in adult patients with cirrhosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Puneeta Tandon, MD, FRCPC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Leah Gramlich, MD, FRCPC</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Seres, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 29, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Protein-calorie malnutrition is common in patients with cirrhosis, and it has been associated with complications including variceal bleeding, ascites, increased surgical morbidity and mortality, reduced survival, and possibly worsening liver function. Recognizing malnutrition is important because nutrition intervention has been associated with improved outcomes.</p><p>This topic will discuss evaluating nutritional status in ambulatory adult patients with cirrhosis and dietary management. The diagnosis and management of cirrhosis are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1263.html" rel="external">"Cirrhosis in adults: Overview of complications, general management, and prognosis"</a>.)</p><p></p><p>Nutrition support for patients who are acutely ill is discussed separately. (See  <a class="medical medical_review" href="/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a>.)</p><p>Nutrition support for patients with alcohol-associated hepatitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/87052.html" rel="external">"Management and prognosis of alcoholic hepatitis", section on 'Nutrition'</a>.)</p><p>Nutritional status in patients with sustained heavy alcohol use is discussed separately. (See  <a class="medical medical_review" href="/d/html/14614.html" rel="external">"Nutritional status in patients with sustained heavy alcohol use"</a>.)</p><p class="headingAnchor" id="H3554012438"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>The definition of malnutrition and related terms (frailty, sarcopenia) has varied across published studies in hepatology and other specialties. To promote consistency across studies, nutrition-related terminology for patients with cirrhosis was developed by expert consensus as part of society practice guidance [<a href="#rid1">1-4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Malnutrition</strong> – Malnutrition refers to imbalance (deficiency or excess) of nutrients that causes measurable adverse effects on tissue/body form (ie, body shape, size, composition), function, and/or clinical outcome. Malnutrition is often used as a synonym for undernutrition [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1">The term "disease-related malnutrition" is used to describe a syndrome of wasting caused by systemic illness that is unrelated and unresponsive to nutrition support. Patients with disease-related malnutrition are probably more likely to develop problems with oral intake, and this is discussed separately. (See  <a class="medical medical_review" href="/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frailty</strong> – For patients with cirrhosis, frailty describes limited physical function due to impaired muscle contraction and muscle weakness [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sarcopenia</strong> – Sarcopenia is the generalized loss of muscle mass and function [<a href="#rid1">1</a>].</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span></p><p class="headingAnchor" id="H3379111549"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>Disease-related malnutrition has been reported in 50 to 100 percent of patients with decompensated cirrhosis and in approximately 20 percent of patients with compensated cirrhosis [<a href="#rid5">5,6</a>].</p><p class="headingAnchor" id="H971638495"><span class="h2">Contributing factors</span><span class="headingEndMark"> — </span>Factors that contribute to malnutrition in patients with cirrhosis can be broadly categorized as the following, although some factors are interrelated [<a href="#rid1">1,5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Impaired intake – Reduced dietary intake may be related to symptoms such as anorexia, nausea, cognitive changes related to hepatic encephalopathy, and abdominal distension from ascites. A sodium-restricted diet and alcohol use may also contribute to reduced dietary intake.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Impaired uptake – Malabsorption and maldigestion of nutrients can result from altered bile salt regulation, bacterial overgrowth, altered intestinal motility, intestinal inflammation, and increased intestinal permeability.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cirrhosis-related factors – Cirrhosis represents an accelerated state of wasting, and fuels other than glucose (ie, protein, lipids) are used [<a href="#rid7">7</a>]. There is an overall loss of protein from reduced synthesis of urea and liver proteins, reduced intestinal protein absorption, and increased urinary nitrogen excretion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physical inactivity – Physical inactivity may contribute to reduced muscle mass [<a href="#rid8">8</a>]. Hepatic encephalopathy is associated with reduced physical activity [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other factors – For some patients with cirrhosis, metabolic status contributes to the imbalance between calorie requirements and dietary intake [<a href="#rid10">10,11</a>]. Some liver diseases have been associated with a chronic inflammatory state that may lead to reduced muscle protein synthesis [<a href="#rid12">12</a>]. For older patients with cirrhosis, age-related factors contribute to sarcopenia [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/14605.html" rel="external">"Normal aging", section on 'Muscle'</a>.)</p><p></p><p class="headingAnchor" id="H1976251658"><span class="h1">NUTRITION SCREENING</span><span class="headingEndMark"> — </span>For patients with cirrhosis who do not meet criteria for nutrition assessment, nutrition risk screening tools are a rapid strategy to identify at-risk patients who may benefit from a comprehensive nutritional assessment. (See <a class="local">'Nutrition assessment'</a> below.)</p><p>We use nutrition screening tools in the inpatient and outpatient settings. Small studies have evaluated the Liver Disease Undernutrition Screening Tool [<a href="#rid14">14</a>], the Nutritional Risk Screening-2002 [<a href="#rid15">15</a>], the Royal Free Hospital-Nutritional Prioritizing Tool (RFH-NPT) [<a href="#rid16">16</a>], and the Patient Generated Subjective Global Assessment [<a href="#rid17">17</a>]. Although further validation is required, the use of RFH-NPT is supported by society guidelines [<a href="#rid1">1,2</a>]. The RFH-NPT score is based on several factors, including fluid retention, body mass index (BMI), weight loss, and dietary intake  (<a class="graphic graphic_figure graphicRef135039" href="/d/graphic/135039.html" rel="external">figure 1</a>) [<a href="#rid16">16</a>]. Patients are classified into three nutritional risk categories (low, moderate, and high risk). Patients with selected conditions such as acute alcohol-associated hepatitis or who require enteral tube feeding are deemed as high risk. The RFH-NPT has been correlated with outcomes such as patient survival and quality of life [<a href="#rid16">16</a>]. From a practical perspective, two questions that can be used at every clinical encounter and may alert the clinician to risk for malnutrition are "Are you eating less than normal?" and "Have you lost weight without trying?" [<a href="#rid18">18</a>]. </p><p class="headingAnchor" id="H4047314275"><span class="h1">NUTRITION ASSESSMENT</span><span class="headingEndMark"> — </span>Nutrition assessment is required for all patients with cirrhosis who score at-risk on a nutrition screen or who have the following characteristics [<a href="#rid2">2,5,6,19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Body mass index (BMI) &lt;18.5 kg/m<sup>2</sup></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Decompensated cirrhosis (or Child-Pugh class C disease) (see  <a class="medical medical_review" href="/d/html/1263.html" rel="external">"Cirrhosis in adults: Overview of complications, general management, and prognosis", section on 'Prognosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients being evaluated for liver transplantation</p><p></p><p class="headingAnchor" id="H79037483"><span class="h2">Diagnosis of malnutrition</span><span class="headingEndMark"> — </span>The diagnosis of malnutrition is typically based on clinical assessment after reviewing the following data (see <a class="local">'Assessment tools'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical history (eg, weight loss, activity level, disease-specific symptoms such as early satiety related to ascites)</p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination (focusing on loss of muscle mass)</p><p class="bulletIndent1"><span class="glyph">●</span>Body mass index (BMI) (eg, &lt;18.5 kg/m<sup>2</sup>)</p><p class="bulletIndent1"><span class="glyph">●</span>Dietary intake (eg, intake of solids and liquids)</p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory studies  (<a class="graphic graphic_table graphicRef135278" href="/d/graphic/135278.html" rel="external">table 1</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Global assessment tool (eg, subjective global assessment [SGA]  (<a class="graphic graphic_form graphicRef63581" href="/d/graphic/63581.html" rel="external">form 1</a>), Royal Free Hospital-Subjective Global Assessment [RFH-SGA])  (<a class="graphic graphic_algorithm graphicRef134876" href="/d/graphic/134876.html" rel="external">algorithm 1</a>)</p><p></p><p>Identifying patients with malnutrition is important because nutritional status influences morbidity and mortality [<a href="#rid20">20,21</a>]. The assessment for malnutrition in patients with cirrhosis typically includes a focused history, physical examination, and laboratory studies. Some clinicians also use an assessment tool (eg, the SGA, or the RFH-SGA, which is specific to cirrhosis) [<a href="#rid22">22</a>]. Use of specialized testing (eg, cross-sectional imaging [CT scan], bioelectrical impedance analysis [BIA]) is mainly limited to research settings because of factors such as availability, need for radiation/contrast exposure and/or special equipment, and cost (see <a class="local">'Specialized methods'</a> below). However, there is no gold standard for evaluating nutritional status in patients with cirrhosis, and clinical practice varies.</p><p class="headingAnchor" id="H3965749381"><span class="h2">Assessment tools</span></p><p class="headingAnchor" id="H4"><span class="h3">History</span><span class="headingEndMark"> — </span>Historical elements of the evaluation include:</p><p class="bulletIndent1"><span class="glyph">●</span>Weight – Serial measurements of body weight offer a simple assessment for nutritional adequacy and change in nutritional status. Patients are questioned about their usual weight, recent weight loss (ie, during the previous two weeks), and weight loss over six months. Unintentional weight loss of &gt;10 percent over six months is considered clinically significant. However, weight history may be less useful for assessing patients with decompensated cirrhosis because of weight fluctuations related to fluid retention and diuretic therapy. If fluid retention is a concern, we estimate dry weight by using post-paracentesis weight or by subtracting a percentage of weight based on the amount of fluid retention (mild, 5 percent; moderate, 10 percent; severe, 15 percent; an additional 5 percent is subtracted in patients with bilateral pedal edema to the knees) [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dietary assessment – Food intake can be assessed by 24-hour dietary recall. The patient recounts the frequency and types of meals and snacks on a typical day, intake of food from each of the food groups, and the use of nutritional supplements. Although specific food choices are not documented in the patient's chart, the dietary recall process assists with an overall appraisal for balanced dietary intake. In clinical practice, a registered dietitian often performs the dietary assessment. (See  <a class="medical medical_review" href="/d/html/5366.html" rel="external">"Dietary assessment in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluating for food insecurity and other issues – We inquire as to social issues such as access and affordability of food, ability to prepare meals, and the role of family members in food preparation [<a href="#rid23">23</a>]. We also question patients about appetite, symptoms that can impact dietary intake (eg, nausea, early satiety, anxiety, depression), and alcohol consumption. The evaluation of common gastrointestinal symptoms that often impact dietary intake (eg, nausea, diarrhea) is discussed separately. (See  <a class="medical medical_review" href="/d/html/2537.html" rel="external">"Approach to the adult with nausea and vomiting"</a> and  <a class="medical medical_review" href="/d/html/2591.html" rel="external">"Approach to the adult with chronic diarrhea in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1">Nutritional issues related to sustained heavy alcohol use are discussed separately. (See  <a class="medical medical_review" href="/d/html/14614.html" rel="external">"Nutritional status in patients with sustained heavy alcohol use"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms of nutritional deficiency – We assess for clinical features of micronutrient deficiency. These include dermatitis (zinc, vitamin A, niacin) , night blindness or photophobia (vitamin A), burning of the mouth or tongue (vitamin B12, folate), easy bruising (vitamin C, vitamin K), and paresthesia (thiamine, pyridoxine)  (<a class="graphic graphic_table graphicRef79983" href="/d/graphic/79983.html" rel="external">table 2</a>).</p><p></p><p class="headingAnchor" id="H10"><span class="h3">Physical examination</span><span class="headingEndMark"> — </span>Physical examination is focused on the following:</p><p class="bulletIndent1"><span class="glyph">●</span>We measure patient height and weight and use it to determine BMI (<a class="calc calc_professional" href="/d/html/13478.html" rel="external">calculator 1</a>). Physical findings such as pedal edema and ascites are noted with weight measurement because weight fluctuates with fluid retention. However, there is no validated method to adjust for volume overload in patients with cirrhosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We assess for ankle or sacral edema, ascites, muscle wasting (as determined in the temporalis muscle, quadriceps, and deltoids), and loss of subcutaneous fat (as determined in the triceps, chest, and eye sockets).</p><p></p><p class="headingAnchor" id="H12"><span class="h3">Laboratory studies</span><span class="headingEndMark"> — </span>The approach to laboratory testing is informed by severity of cirrhosis and etiology of liver disease as outlined in the table  (<a class="graphic graphic_table graphicRef135278" href="/d/graphic/135278.html" rel="external">table 1</a>) [<a href="#rid24">24</a>].</p><p>For all patients with cirrhosis, we obtain complete blood count, serum albumin, serum creatinine, international normalized ratio (INR), serum 25-hydroxyvitamin D, and C-reactive protein (CRP). CRP may be useful in assessing degree of catabolism and interpreting measures of other nutrients. For example, serum 25-hydroxyvitamin D and albumin levels may decrease in inflammatory states and thus, a low vitamin D level in patients with inflammation may not represent deficiency. (See  <a class="medical medical_review" href="/d/html/7483.html" rel="external">"Acute phase reactants", section on 'C-reactive protein'</a>.)</p><p>For selected patients with cirrhosis (ie, those with decompensated cirrhosis, alcohol-associated cirrhosis, or cirrhosis related to cholestatic liver disease), we obtain additional laboratory tests as outlined in the table  (<a class="graphic graphic_table graphicRef135278" href="/d/graphic/135278.html" rel="external">table 1</a>).</p><p>Limitations of laboratory assessment in patients with cirrhosis include:</p><p class="bulletIndent1"><span class="glyph">●</span>Vitamin B12 – Patients with cirrhosis may have elevated serum vitamin B12 levels [<a href="#rid25">25</a>]. Vitamin B12 is stored in the liver and may be released with hepatocellular injury. In addition, decreased vitamin B12 clearance may contribute to elevated levels. However, other causes of an elevated serum B12 level should be evaluated before attributing it to cirrhosis, and this is discussed separately. (See  <a class="medical medical_review" href="/d/html/7153.html" rel="external">"Causes and pathophysiology of vitamin B12 and folate deficiencies", section on 'Elevated levels of vitamin B12 or folate'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Liver-synthesized proteins – The liver is the major site where serum proteins (albumin and coagulation factors) are synthesized. Albumin levels are influenced by acute changes such as catabolism, hepatic inflammation, decreased production, capillary leak, and sequestration. Thus, the use of these tests may be limited in patients with decompensated cirrhosis and synthetic dysfunction. Tests of the liver's biosynthetic capacity are discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/3566.html" rel="external">"Tests of the liver's biosynthetic capacity (eg, albumin, coagulation factors, prothrombin time)"</a>.)</p><p></p><p>Testosterone levels may also help guide therapy in male patients who are malnourished [<a href="#rid26">26</a>]. Symptoms of hypogonadism may overlap with those of chronic liver disease, and the evaluation of male patients with suspected hypogonadism is discussed separately. (See  <a class="medical medical_review" href="/d/html/7462.html" rel="external">"Clinical features and diagnosis of male hypogonadism"</a>.)</p><p class="headingAnchor" id="H3341482069"><span class="h3">Assessment questionnaires</span><span class="headingEndMark"> — </span>Standardized questionnaires can be used as part of nutritional assessment to identify patients who have malnutrition [<a href="#rid16">16,27-29</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subjective global assessment</strong> – The SGA can be administered at the bedside and includes a focused history and physical examination  (<a class="graphic graphic_form graphicRef63581" href="/d/graphic/63581.html" rel="external">form 1</a>) [<a href="#rid30">30-32</a>]. The historical components of the SGA include weight loss, change in dietary intake, gastrointestinal symptoms, functional capacity, and metabolic demand associated with the disease state. Physical examination components include edema, ascites, muscle wasting, and loss of subcutaneous fat. The components are combined to obtain an SGA rating that ranges from well-nourished to severely malnourished.</p><p></p><p class="bulletIndent1">While the SGA is accessible and easy to administer, the sensitivity of the SGA in patients with cirrhosis has been questioned in several studies [<a href="#rid33">33-35</a>]. In addition, although SGA correlates with postoperative outcomes in patients without cirrhosis [<a href="#rid30">30-32</a>], there is growing evidence that other assessments (eg, muscle mass measurement) may be more useful for predicting clinical outcomes [<a href="#rid33">33-38</a>]. In a study of 315 patients with cirrhosis who were evaluated with skeletal muscle index (SMI) using cross-sectional imaging and with the SGA, there was weak concordance between sarcopenia (as determined by SMI) and the SGA [<a href="#rid35">35</a>]. In a study of 79 patients with cirrhosis, malnutrition was detected by the SGA in 25 patients (32 percent), while body composition analysis identified 48 patients with malnutrition (60 percent) [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Royal Free Hospital-Subjective Global Assessment</strong> – Because of the limitations of the SGA in patients with cirrhosis, the RFH-SGA was developed  (<a class="graphic graphic_algorithm graphicRef134876" href="/d/graphic/134876.html" rel="external">algorithm 1</a>). This assessment incorporates subjective and objective variables (BMI, midarm muscle circumference, and dietary intake) [<a href="#rid39">39</a>]. Although the RFH-SGA requires more time than the SGA, it has shown promise as a predictor of mortality and of post-transplantation outcomes [<a href="#rid37">37,40</a>]. Studies that validate the RFH-SGA are awaited.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assess for frailty</strong> – Selecting an assessment for frailty is individualized and guided by equipment availability, center experience, and the patient's ability to participate in testing. Global tests of frailty include the clinical frailty scale and the frailty index [<a href="#rid41">41</a>]. Short, survey-based instruments that do not involve patient participation include those that assess activities of daily living and performance status (ie, measure of patient's functional capacity)  (<a class="graphic graphic_table graphicRef58785" href="/d/graphic/58785.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/2206.html" rel="external">"Survival estimates in advanced terminal cancer", section on 'Performance status'</a>.)</p><p></p><p class="bulletIndent1">Measures of physical frailty that require patient participation include the Liver Frailty Index (ie, hand grip strength, balance testing, chair sit-to-stand), the Short Physical Performance Battery (ie, hand grip strength, balance testing, short gait speed), and the six-minute walk test [<a href="#rid19">19,33,41-47</a>]. (See  <a class="medical medical_review" href="/d/html/3010.html" rel="external">"Frailty", section on 'Concepts and definitions'</a>.)</p><p></p><p class="bulletIndent1">For patients with cirrhosis, studies suggest that a diagnosis of frailty has been associated with an increased risk of mortality [<a href="#rid48">48</a>].</p><p></p><p class="headingAnchor" id="H3955487263"><span class="h2">Specialized methods</span></p><p class="headingAnchor" id="H1959222640"><span class="h3">Body composition testing</span><span class="headingEndMark"> — </span>Assessment of muscle mass and bone mass can contribute to better understanding of nutritional status in patients with cirrhosis. However, use of specialized body composition assessment methods in clinical practice is limited by factors such as availability and cost. Thus, specialized methods are typically reserved for research settings.</p><p>Methods to assess body composition include (see  <a class="medical medical_review" href="/d/html/5381.html" rel="external">"Determining body composition in adults"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Computed tomography – Computed tomography (CT) may be used to assess for sarcopenia (loss of muscle mass) in patients with cirrhosis if abdominal CT is being performed for other indications (eg, liver transplantation evaluation). Otherwise, cross-sectional imaging for assessing body composition is mainly used in research settings due to limited availability of specialized equipment required for data analysis, radiation and contrast exposure, and cost. Strategies to increase access to methods for analyzing body composition remain in development [<a href="#rid49">49</a>]. Despite these limitations, evaluating for sarcopenia with abdominal CT has demonstrated good correlation with pretransplant morbidity and mortality across studies [<a href="#rid2">2,19,20,48</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bioelectrical impedance analysis – BIA is performed by applying electrodes to one arm and one leg or by standing on a specialized scale. BIA measures impedance or resistance to the flow of an electrical current within the body, which is used to determine total body water and can distinguish muscle mass from fat. However, the patient's volume status may impact the results because BIA uses estimated water content to calculate muscle mass [<a href="#rid50">50-52</a>]. In a study of 136 patients with cirrhosis, BIA phase angle was moderately correlated with CT scan-based muscle mass using the SMI, irrespective of the presence of ascites [<a href="#rid51">51</a>]. In addition, BIA phase angle was an independent predictor of mortality.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anthropometry – Anthropometry is a tool used to assess body fat and lean tissue stores that is largely unaffected by fluid overload. Commonly used measurements include midarm muscle circumference, which estimates muscle mass at the midarm level, and skinfold thickness, which may be used to estimate total body fat percentage [<a href="#rid53">53,54</a>]. Limitations to anthropometry include interobserver variability and accuracy in adults; thus, more advanced measures of body composition (eg, CT scan) have replaced anthropometry in some centers where body composition in adults is assessed [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dual energy X-ray absorptiometry – Dual energy X-ray absorptiometry (DEXA) accurately estimates fat mass in patients with liver disease but does not provide as accurate an assessment of lean body mass [<a href="#rid56">56-58</a>]. This inaccuracy is most likely related to the increase in extracellular water in patients with decompensated cirrhosis. However, the use of appendicular skeletal muscle measurements may improve testing accuracy [<a href="#rid57">57,58</a>].</p><p></p><p class="bulletIndent1">DEXA is commonly used in the diagnosis of low bone mass in patients with cholestatic liver disease (eg, primary biliary cholangitis). (See  <a class="medical medical_review" href="/d/html/3606.html" rel="external">"Evaluation and treatment of low bone mass in primary biliary cholangitis (primary biliary cirrhosis)"</a>.)</p><p></p><p class="headingAnchor" id="H74885317"><span class="h1">MANAGEMENT PRINCIPLES</span></p><p class="headingAnchor" id="H1128433231"><span class="h2">General measures</span><span class="headingEndMark"> — </span>General measures for patients with cirrhosis include [<a href="#rid2">2,59</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nutrition education – We provide <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fcirrhosiscare.ca%2Fhealthy-living-patients%2Fcirrhosis-nutrition-info%2F&amp;token=dCX0iYeWchDfH7q0%2FUMmVORo%2F%2BSYIr7dS0ClDM0BIeQgAKFf9c1h9KRVPMntY8P4ZTtuJSrYhshQQmId3I1gzXaIA6WewTx3Lk5%2Fk8oXOrc%3D&amp;TOPIC_ID=3598" target="_blank">patient education resources</a> including nutrition handouts and digital resources for patients with cirrhosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Referral to registered dietitian – We routinely refer patients with malnutrition to a registered dietitian for an individualized nutritional plan that incorporates the patient's nutritional habits and food preferences [<a href="#rid1">1</a>]. This includes tailored calorie and protein intake recommendations based on the patient's nutritional status, current dietary intake, and body mass index (BMI).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoid prolonged fasting – Patients are advised to eat at regular intervals (eg, every four hours) while awake, and to eat breakfast as well as a late evening snack. Oral intake at regular intervals has been associated with improved nutritional status for patients with cirrhosis. In a trial including 103 patients with cirrhosis, night-time oral nutrition supplements resulted in greater improvement in total body protein after 12 months compared with daytime oral supplements [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoid raw or undercooked foods – Patients are advised to avoid eating raw or undercooked shellfish, fish, meat, and unpasteurized dairy products [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/d/html/3128.html" rel="external">"Vibrio vulnificus infection"</a>.)</p><p></p><p class="bulletIndent1">In the United States, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.foodsafety.gov%2Fpeople-at-risk%2Fpeople-with-weakened-immune-systems&amp;token=MuxYdXBx2hHYaZJN7IXp3PBjlxyMWHTCHBSj%2FnCMxWG2YK3ovtjpcBqz5BC%2BnqOhu1BiORbsJzygwAuqrRRLYDlohDyyCHcLmKPOixI25wk%3D&amp;TOPIC_ID=3598" target="_blank">foodsafety.gov</a> provides detailed advice on food safety for patients who are immunocompromised, including those with liver disease [<a href="#rid62">62</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vitamin supplementation – We advise patients to take a daily multivitamin, and we provide additional micronutrient repletion based on specific deficiencies  (<a class="graphic graphic_table graphicRef81151" href="/d/graphic/81151.html" rel="external">table 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lifestyle intervention – We encourage patients to increase physical activity because data have suggested that physical activity (in combination with nutritional counseling) was associated with improved muscle function and muscle mass [<a href="#rid8">8,63</a>]. (See  <a class="medical medical_review" href="/d/html/120020.html" rel="external">"Exercise prescription and guidance for adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Manage underlying liver disease – Measures to reduce liver inflammation (eg, alcohol abstinence, treatment for chronic viral hepatitis) are implemented as part of a comprehensive nutritional plan.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multidisciplinary care – Nutrition management typically involves a multidisciplinary team including specialists from primary care, gastroenterology/hepatology, and physical and exercise therapy.</p><p></p><p class="headingAnchor" id="H1497460421"><span class="h2">Target daily intake</span><span class="headingEndMark"> — </span>Target daily intake is determined by estimating the patient's total calorie and protein needs, and this is often done with the assistance of a registered dietitian. (See <a class="local">'Total calorie intake'</a> below and <a class="local">'Protein intake'</a> below.)</p><p class="headingAnchor" id="H2456669056"><span class="h3">Total calorie intake</span><span class="headingEndMark"> — </span>Total calorie intake is based on resting energy expenditure (REE) and can be assessed using indirect calorimetry to inform personalized nutrition prescriptions.</p><p>If indirect calorimetry measurement is not available, alternative methods for estimating total calorie intake include using a predictive equation or a weight-based equation [<a href="#rid59">59</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Predictive equations – In the absence of indirect calorimetry, we typically use predictive equations such as the Harris-Benedict equation, recognizing that they can underestimate the REE [<a href="#rid10">10,64</a>]. The accuracy of the Harris-Benedict equation in determining REE is subject to individual variability based upon the factors included in the equation (weight, height, age, sex).</p><p></p><p class="bulletIndent1">The Harris-Benedict equations for males and for females are presented separately. (See  <a class="medical medical_review" href="/d/html/820.html" rel="external">"Nutritional demands and enteral formulas for adult surgical patients", section on 'Predictive equation: Harris-Benedict'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Weight-based equations – An alternative method for estimating calorie needs is use of a weight-based equation. Whether ideal body weight should be used in weight-based calculations is uncertain, and society guidelines differ in their approach [<a href="#rid2">2,48</a>]. Until further data are available, we support the following options:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients without obesity – Target daily minimum energy intake is 35 kcal/kg</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with obesity – Target daily minimum energy intake may be either a tailored, moderately hypocaloric diet (ie, 500 to 800 kcal/day) or a BMI-stratified intake target:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with BMI &lt;30 kg/m<sup>2</sup>, the target daily minimum energy intake is 35 kcal/kg</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with BMI 30 to 40 kg/m<sup>2</sup>, the target daily minimum energy intake is 25 to 35 kcal/kg</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with BMI ≥40 kg/m<sup>2</sup>, the target daily minimum intake is 20 to 25 kcal/kg</p><p></p><p class="bulletIndent1">An online tool for calculating the patient's nutrition prescription that uses the BMI-stratified intake and estimated dry weight can be found <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwellnesstoolbox.ca%2Fcirrhosis%2Fnutrition%2Fnutrition-prescription-calculator%2F&amp;token=Pzv17YOXvys0EK%2B4lMVQg9d6IX2Zfdv2KZH2Ek4QgLWzZBPIfEfMDLXMOYk21C5UQRH8BAnMmEInPzA%2BizKJzTVEAx3TqOojh4hKTuxn138%3D&amp;TOPIC_ID=3598" target="_blank">here</a> [<a href="#rid65">65</a>].</p><p></p><p class="headingAnchor" id="H258885714"><span class="h3">Protein intake</span><span class="headingEndMark"> — </span>The target daily protein intake is 1.2 to 1.5 g/kg, based on ideal body weight (<a class="calc calc_professional" href="/d/html/13489.html" rel="external">calculator 2</a>). In adults with cirrhosis who are critically ill, the target daily protein intake is 1.2 to 2.0 g/kg, based on ideal body weight [<a href="#rid1">1</a>]. We consult with a dietician to help determine protein requirements for patients with cirrhosis and Class II or III obesity. Additional studies are needed to determine true protein requirements in this patient population to ensure they are not being underdosed. </p><p>We advise patients to consume a diverse range of protein sources (eg, vegetable, chicken, fish, dairy-based proteins), and advise them to consume protein at each meal and with each snack.</p><p class="headingAnchor" id="H881528873"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>Monitoring patients with cirrhosis who are following a nutrition prescription typically includes reassessing weight, physical examination, and laboratory tests every 6 to 12 months  (<a class="graphic graphic_table graphicRef135278" href="/d/graphic/135278.html" rel="external">table 1</a>). Patients with decompensated cirrhosis are monitored with more frequent laboratory testing (every two to three months) because such patients are at risk for electrolyte imbalances and refeeding syndrome. (See  <a class="medical medical_review" href="/d/html/15778.html" rel="external">"Anorexia nervosa in adults and adolescents: The refeeding syndrome"</a>.)</p><p class="headingAnchor" id="H1186871711"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111039.html" rel="external">"Society guideline links: Healthy diet in adults"</a>.)</p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – Nutrition-related terminology for patients with cirrhosis has been developed by expert consensus (see <a class="local">'Terminology'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Malnutrition – Malnutrition refers to an imbalance (deficiency or excess) of nutrients that causes altered body form (body shape, size, composition), function, and/or clinical outcome. Malnutrition is often used as a synonym for undernutrition.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Frailty – Frailty describes limited physical function due to impaired muscle contraction and muscle weakness.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sarcopenia – Sarcopenia is the generalized loss of muscle mass and function.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutritional screening</strong> –<strong> </strong>We use nutrition risk screening tools for patients with cirrhosis who do not meet criteria for a comprehensive nutrition assessment. Nutrition screening may identify additional at-risk patients who may benefit from a nutritional assessment  (<a class="graphic graphic_figure graphicRef135039" href="/d/graphic/135039.html" rel="external">figure 1</a>). (See <a class="local">'Nutrition screening'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutritional assessment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications</strong> – Comprehensive nutrition assessment by a skilled professional (bypassing the need for nutrition screening) is indicated for patients who are at increased risk for malnutrition (see <a class="local">'Nutrition assessment'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with body mass index (BMI) &lt;18.5 kg/m<sup>2</sup></p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with decompensated cirrhosis (or Child-Pugh class C disease)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients who are being evaluated for liver transplantation</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis of malnutrition</strong> – The diagnosis of malnutrition is based on clinical assessment after reviewing the following data (see <a class="local">'Diagnosis of malnutrition'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Clinical history (eg, weight loss, activity level, disease-specific symptoms such as early satiety related to ascites)</p><p class="bulletIndent3"><span class="glyph">-</span>Physical examination (focusing on loss of muscle mass)</p><p class="bulletIndent3"><span class="glyph">-</span>BMI</p><p class="bulletIndent3"><span class="glyph">-</span>Dietary intake (eg, intake of solids and liquids)</p><p class="bulletIndent3"><span class="glyph">-</span>Laboratory studies  (<a class="graphic graphic_table graphicRef135278" href="/d/graphic/135278.html" rel="external">table 1</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>A global assessment tool (eg, subjective global assessment  (<a class="graphic graphic_form graphicRef63581" href="/d/graphic/63581.html" rel="external">form 1</a>), the Royal Free Hospital-Subjective Global Assessment  (<a class="graphic graphic_algorithm graphicRef134876" href="/d/graphic/134876.html" rel="external">algorithm 1</a>))</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>General measures</strong> – General measures for patients with cirrhosis include (see <a class="local">'General measures'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with malnutrition, referral to a registered dietitian for dietary counseling</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Avoid prolonged fasting (ie, eating at regular intervals while awake and including a late evening snack)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Avoid raw or undercooked shellfish, fish, meat, and avoid unpasteurized dairy products </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Manage underlying liver disease to control inflammation (eg, treatment for chronic viral hepatitis, alcohol abstinence)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Vitamin supplementation consisting of a daily multivitamin and additional micronutrient repletion based on specific deficiencies  (<a class="graphic graphic_table graphicRef81151" href="/d/graphic/81151.html" rel="external">table 4</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Encourage increased physical activity</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Estimate target daily intake</strong> – Target daily intake is based on resting energy expenditure (REE) that can be assessed using indirect calorimetry if such testing available. Alternatives to indirect calorimetry for estimating total calorie and protein needs include (see <a class="local">'Target daily intake'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A predictive equation such as the Harris-Benedict equation. (See  <a class="medical medical_review" href="/d/html/820.html" rel="external">"Nutritional demands and enteral formulas for adult surgical patients", section on 'Predictive equation: Harris-Benedict'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>A weight-based equation with target daily intake stratified by BMI. An online tool for calculating the patient's nutrition prescription that uses the BMI-stratified intake can be found <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwellnesstoolbox.ca%2Fcirrhosis%2Fnutrition%2Fnutrition-prescription-calculator%2F&amp;token=Pzv17YOXvys0EK%2B4lMVQg9d6IX2Zfdv2KZH2Ek4QgLWzZBPIfEfMDLXMOYk21C5UQRH8BAnMmEInPzA%2BizKJzTVEAx3TqOojh4hKTuxn138%3D&amp;TOPIC_ID=3598" target="_blank">here</a>.</p><p></p><p class="bulletIndent2">Target daily protein intake is 1.2 to 1.5 g/kg, based on ideal body weight (<a class="calc calc_professional" href="/d/html/13489.html" rel="external">calculator 2</a>).</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lai JC, Tandon P, Bernal W, et al. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 74:1611.</a></li><li><a class="nounderline abstract_t">European Association for the Study of the Liver. Electronic address: <span class="__cf_email__" data-cfemail="620703110e0d04040b0107220703110e0d04040b01074c0717">[email protected]</span>, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol 2019; 70:172.</a></li><li><a class="nounderline abstract_t">Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013; 14:392.</a></li><li><a class="nounderline abstract_t">Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48:16.</a></li><li><a class="nounderline abstract_t">Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012; 10:117.</a></li><li><a class="nounderline abstract_t">Huisman EJ, Trip EJ, Siersema PD, et al. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol 2011; 23:982.</a></li><li><a class="nounderline abstract_t">Charlton MR. Alcoholic Liver Disease: Energy and Protein Metabolism in Alcoholic Liver Disease. Clin Liver Dis 1998; 2:781.</a></li><li><a class="nounderline abstract_t">Zenith L, Meena N, Ramadi A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12:1920.</a></li><li><a class="nounderline abstract_t">Tapper EB, Aberasturi D, Zhao Z, et al. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis. Aliment Pharmacol Ther 2020; 51:1397.</a></li><li><a class="nounderline abstract_t">Eslamparast T, Vandermeer B, Raman M, et al. Are Predictive Energy Expenditure Equations Accurate in Cirrhosis? Nutrients 2019; 11.</a></li><li><a class="nounderline abstract_t">Limon-Miro AT, Jackson CD, Eslamparast T, et al. Predicted estimates of resting energy expenditure have limited clinical utility in patients with cirrhosis. J Hepatol 2022; 77:98.</a></li><li><a class="nounderline abstract_t">Gao B, Tsukamoto H. Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe? Gastroenterology 2016; 150:1704.</a></li><li><a class="nounderline abstract_t">Welch N, Attaway A, Bellar A, et al. Compound Sarcopenia in Hospitalized Patients with Cirrhosis Worsens Outcomes with Increasing Age. Nutrients 2021; 13:659.</a></li><li><a class="nounderline abstract_t">Booi AN, Menendez J, Norton HJ, et al. Validation of a Screening Tool to Identify Undernutrition in Ambulatory Patients With Liver Cirrhosis. Nutr Clin Pract 2015; 30:683.</a></li><li><a class="nounderline abstract_t">Yosry A, Omran D, Said M, et al. Impact of nutritional status of Egyptian patients with end-stage liver disease on their outcomes after living donor liver transplantation. J Dig Dis 2014; 15:321.</a></li><li><a class="nounderline abstract_t">Borhofen SM, Gerner C, Lehmann J, et al. The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis. Dig Dis Sci 2016; 61:1735.</a></li><li><a class="nounderline abstract_t">Ma CH, Cruz C, Eslamparast T, et al. The patient generated subjective global assessment short form is a useful screening tool to detect risk for malnutrition in patients with cirrhosis. Clin Nutr ESPEN 2022; 50:330.</a></li><li><a class="nounderline abstract_t">Laporte M, Keller HH, Payette H, et al. Validity and reliability of the new Canadian Nutrition Screening Tool in the 'real-world' hospital setting. Eur J Clin Nutr 2015; 69:558.</a></li><li><a class="nounderline abstract_t">Tandon P, Raman M, Mourtzakis M, Merli M. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology 2017; 65:1044.</a></li><li><a class="nounderline abstract_t">van Vugt JL, Levolger S, de Bruin RW, et al. Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation. Am J Transplant 2016; 16:2277.</a></li><li><a class="nounderline abstract_t">Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 2016; 43:765.</a></li><li><a class="nounderline abstract_t">Morgan MY, Madden AM, Soulsby CT, Morris RW. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology 2006; 44:823.</a></li><li><a class="nounderline abstract_t">Golovaty I, Tien PC, Price JC, et al. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. J Nutr 2020; 150:91.</a></li><li><a class="nounderline abstract_t">Johnson TM, Overgard EB, Cohen AE, DiBaise JK. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract 2013; 28:15.</a></li><li><a class="nounderline abstract_t">Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003; 36:585.</a></li><li><a class="nounderline abstract_t">Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: abnormalities and implications. J Gastroenterol Hepatol 2015; 30:244.</a></li><li><a class="nounderline abstract_t">Boulhosa RSSB, Lourenço RP, Côrtes DM, et al. Comparison between criteria for diagnosing malnutrition in patients with advanced chronic liver disease: GLIM group proposal versus different nutritional screening tools. J Hum Nutr Diet 2020; 33:862.</a></li><li><a class="nounderline abstract_t">Wu Y, Zhu Y, Feng Y, et al. Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002. Br J Nutr 2020; 124:1293.</a></li><li><a class="nounderline abstract_t">Traub J, Bergheim I, Horvath A, Stadlbauer V. Validation of Malnutrition Screening Tools in Liver Cirrhosis. Nutrients 2020; 12.</a></li><li><a class="nounderline abstract_t">Detsky AS, Baker JP, Mendelson RA, et al. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr 1984; 8:153.</a></li><li><a class="nounderline abstract_t">Nutritional status in cirrhosis. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. J Hepatol 1994; 21:317.</a></li><li><a class="nounderline abstract_t">Hasse J, Strong S, Gorman MA, Liepa G. Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition 1993; 9:339.</a></li><li><a class="nounderline abstract_t">Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005; 21:113.</a></li><li><a class="nounderline abstract_t">Figueiredo FA, Perez RM, Freitas MM, Kondo M. Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis. J Gastroenterol 2006; 41:476.</a></li><li><a class="nounderline abstract_t">Moctezuma-Velazquez C, Ebadi M, Bhanji RA, et al. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis. Clin Nutr 2019; 38:2696.</a></li><li><a class="nounderline abstract_t">Stephenson GR, Moretti EW, El-Moalem H, et al. Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation 2001; 72:666.</a></li><li><a class="nounderline abstract_t">Gunsar F, Raimondo ML, Jones S, et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006; 24:563.</a></li><li><a class="nounderline abstract_t">Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001; 17:761.</a></li><li><a class="nounderline abstract_t">Bishop CW, Bowen PE, Ritchey SJ. Norms for nutritional assessment of American adults by upper arm anthropometry. Am J Clin Nutr 1981; 34:2530.</a></li><li><a class="nounderline abstract_t">Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score. J Cachexia Sarcopenia Muscle 2017; 8:113.</a></li><li><a class="nounderline abstract_t">Lai JC, Dodge JL, Kappus MR, et al. Changes in frailty are associated with waitlist mortality in patients with cirrhosis. J Hepatol 2020; 73:575.</a></li><li><a class="nounderline abstract_t">Wang CW, Feng S, Covinsky KE, et al. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study. Transplantation 2016; 100:1692.</a></li><li><a class="nounderline abstract_t">Tapper EB, Konerman M, Murphy S, Sonnenday CJ. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant 2018; 18:2566.</a></li><li><a class="nounderline abstract_t">Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146.</a></li><li><a class="nounderline abstract_t">Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49:M85.</a></li><li><a class="nounderline abstract_t">Lai JC, Feng S, Terrault NA, et al. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant 2014; 14:1870.</a></li><li><a class="nounderline abstract_t">Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology 2017; 66:564.</a></li><li><a class="nounderline abstract_t">Tandon P, Montano-Loza AJ, Lai JC, et al. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol 2021; 75 Suppl 1:S147.</a></li><li><a class="nounderline abstract_t">Paris MT, Tandon P, Heyland DK, et al. Automated body composition analysis of clinically acquired computed tomography scans using neural networks. Clin Nutr 2020; 39:3049.</a></li><li><a class="nounderline abstract_t">Pirlich M, Schütz T, Spachos T, et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000; 32:1208.</a></li><li><a class="nounderline abstract_t">Ruiz-Margáin A, Xie JJ, Román-Calleja BM, et al. Phase Angle From Bioelectrical Impedance for the Assessment of Sarcopenia in Cirrhosis With or Without Ascites. Clin Gastroenterol Hepatol 2021; 19:1941.</a></li><li><a class="nounderline abstract_t">Romeiro FG, Augusti L. Nutritional assessment in cirrhotic patients with hepatic encephalopathy. World J Hepatol 2015; 7:2940.</a></li><li><a class="nounderline abstract_t">Figueiredo FA, Dickson ER, Pasha TM, et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000; 6:575.</a></li><li><a class="nounderline abstract_t">Alberino F, Gatta A, Amodio P, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17:445.</a></li><li><a class="nounderline abstract_t">Giusto M, Lattanzi B, Albanese C, et al. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol 2015; 27:328.</a></li><li><a class="nounderline abstract_t">Hara N, Iwasa M, Iwata K, et al. Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites. Hepatol Res 2009; 39:1072.</a></li><li><a class="nounderline abstract_t">Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: Dual-energy x-ray absorptiometry compared with computed tomography. Nutrition 2019; 61:93.</a></li><li><a class="nounderline abstract_t">Sinclair M, Hoermann R, Peterson A, et al. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk. Liver Int 2019; 39:1089.</a></li><li><a class="nounderline abstract_t">Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr 2019; 38:485.</a></li><li><a class="nounderline abstract_t">Plank LD, Gane EJ, Peng S, et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology 2008; 48:557.</a></li><li class="breakAll">Eating, Diet, &amp; Nutrition for Cirrhosis. https://www.niddk.nih.gov/health-information/liver-disease/cirrhosis/eating-diet-nutrition#:~:text=Avoid%20eating%20raw%20or%20undercooked,sodium%20in%20foods%20and%20drinks. (Accessed on September 10, 2023).</li><li class="breakAll">FoodSafety.gov https://www.foodsafety.gov/people-at-risk/people-with-weakened-immune-systems (Accessed on September 10, 2023).</li><li><a class="nounderline abstract_t">Kruger C, McNeely ML, Bailey RJ, et al. Home Exercise Training Improves Exercise Capacity in Cirrhosis Patients: Role of Exercise Adherence. Sci Rep 2018; 8:99.</a></li><li><a class="nounderline abstract_t">Madden AM, Morgan MY. Resting energy expenditure should be measured in patients with cirrhosis, not predicted. Hepatology 1999; 30:655.</a></li><li><a class="nounderline abstract_t">Amodio P, Bemeur C, Butterworth R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology 2013; 58:325.</a></li></ol></div><div id="topicVersionRevision">Topic 3598 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34233031" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30144956" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : EASL Clinical Practice Guidelines on nutrition in chronic liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23764209" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Frailty consensus: a call to action.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30312372" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sarcopenia: revised European consensus on definition and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21893127" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21971339" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Protein energy malnutrition predicts complications in liver cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Alcoholic Liver Disease: Energy and Protein Metabolism in Alcoholic Liver Disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24768811" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32363684" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30720726" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Are Predictive Energy Expenditure Equations Accurate in Cirrhosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35090958" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Predicted estimates of resting energy expenditure have limited clinical utility in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26826669" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33670535" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Compound Sarcopenia in Hospitalized Patients with Cirrhosis Worsens Outcomes with Increasing Age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26024676" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Validation of a Screening Tool to Identify Undernutrition in Ambulatory Patients With Liver Cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24593282" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Impact of nutritional status of Egyptian patients with end-stage liver disease on their outcomes after living donor liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26725059" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35871945" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The patient generated subjective global assessment short form is a useful screening tool to detect risk for malnutrition in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25514899" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Validity and reliability of the new Canadian Nutrition Screening Tool in the 'real-world' hospital setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28027577" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A practical approach to nutritional screening and assessment in cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26813115" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26847265" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17006918" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31504710" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23319353" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Nutrition assessment and management in advanced liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14636871" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Significance of elevated cobalamin (vitamin B12) levels in blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25087838" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Testosterone in men with advanced liver disease: abnormalities and implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32378264" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Comparison between criteria for diagnosing malnutrition in patients with advanced chronic liver disease: GLIM group proposal versus different nutritional screening tools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32600494" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32375271" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Validation of Malnutrition Screening Tools in Liver Cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6538911" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7836699" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nutritional status in cirrhosis. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8400590" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15723736" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16799890" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30545661" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11544428" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16827812" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Nutritional status and prognosis in cirrhotic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11527674" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Nutritional assessment in various stages of liver cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6975563" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Norms for nutritional assessment of American adults by upper arm anthropometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27239424" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32240717" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Changes in frailty are associated with waitlist mortality in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27314169" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30019835" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11253156" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Frailty in older adults: evidence for a phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8126356" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24935609" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Frailty predicts waitlist mortality in liver transplant candidates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28422306" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Development of a novel frailty index to predict mortality in patients with end-stage liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34039486" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Sarcopenia and frailty in decompensated cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32007318" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Automated body composition analysis of clinically acquired computed tomography scans using neural networks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11093726" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32890753" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Phase Angle From Bioelectrical Impedance for the Assessment of Sarcopenia in Cirrhosis With or Without Ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26730273" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Nutritional assessment in cirrhotic patients with hepatic encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10980056" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11399401" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Nutrition and survival in patients with liver cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25569567" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19619257" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30703575" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Assessment of muscle mass depletion in chronic liver disease: Dual-energy x-ray absorptiometry compared with computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30746903" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30712783" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : ESPEN guideline on clinical nutrition in liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18627001" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18627001" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18627001" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29311671" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Home Exercise Training Improves Exercise Capacity in Cirrhosis Patients: Role of Exercise Adherence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10462371" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Resting energy expenditure should be measured in patients with cirrhosis, not predicted.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23471642" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
